Improving a Deep Learning Model to Accurately Diagnose LVNC.
Jaime Rafael BarónGregorio Bernabé GarcíaPilar González-FérezJosé Manuel GarcíaGuillem CasasJosefa González-CarrilloPublished in: Journal of clinical medicine (2023)
Accurate diagnosis of Left Ventricular Noncompaction Cardiomyopathy (LVNC) is critical for proper patient treatment but remains challenging. This work improves LVNC detection by improving left ventricle segmentation in cardiac MR images. Trabeculated left ventricle indicates LVNC, but automatic segmentation is difficult. We present techniques to improve segmentation and evaluate their impact on LVNC diagnosis. Three main methods are introduced: (1) using full 800 × 800 MR images rather than 512 × 512; (2) a clustering algorithm to eliminate neural network hallucinations; (3) advanced network architectures including Attention U-Net, MSA-UNet, and U-Net++.Experiments utilize cardiac MR datasets from three different hospitals. U-Net++ achieves the best segmentation performance using 800 × 800 images, and it improves the mean segmentation Dice score by 0.02 over the baseline U-Net, the clustering algorithm improves the mean Dice score by 0.06 on the images it affected, and the U-Net++ provides an additional 0.02 mean Dice score over the baseline U-Net. For LVNC diagnosis, U-Net++ achieves 0.896 accuracy, 0.907 precision, and 0.912 F1-score outperforming the baseline U-Net. Proposed techniques enhance LVNC detection, but differences between hospitals reveal problems in improving generalization. This work provides validated methods for precise LVNC diagnosis.
Keyphrases
- deep learning
- convolutional neural network
- artificial intelligence
- left ventricular
- machine learning
- heart failure
- mitral valve
- magnetic resonance
- mental health
- rna seq
- pulmonary hypertension
- pulmonary artery
- working memory
- acute myocardial infarction
- acute coronary syndrome
- case report
- quantum dots
- coronary artery disease
- optical coherence tomography
- mass spectrometry
- smoking cessation
- percutaneous coronary intervention
- dna methylation